US 6228862
Treating NIDDM with RXR agonists
expired A61KA61K31/00A61K31/192
Quick answer
US patent 6228862 (Treating NIDDM with RXR agonists) held by Ligand Pharmaceuticals Incorporated expires Mon May 03 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Ligand Pharmaceuticals Incorporated
- Grant date
- Tue May 08 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 03 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 1
- CPC classes
- A61K, A61K31/00, A61K31/192, A61K31/425, A61K31/44